T1	Gene_or_protein	15 19	HER2
T2	Phenotype	36 60	malignant transformation
T3	Disease	102 120	breast cancer that
T4	Pharmacodynamic_phenotype	139 191	resistant to non- anthracycline -based therapies and
T5	Pharmacodynamic_phenotype	192 213	hormonal agents , but
T6	Chemical	226 254	targeted molecular therapy .
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	influences	Arg1:T1	Arg2:T4
R4	influences	Arg1:T1	Arg2:T5
R5	influences	Arg1:T1	Arg2:T6
R6	influences	Arg1:T2	Arg2:T1
R7	influences	Arg1:T2	Arg2:T3
R8	influences	Arg1:T2	Arg2:T4
R9	influences	Arg1:T2	Arg2:T5
R10	influences	Arg1:T2	Arg2:T6
R11	isAssociatedWith	Arg1:T3	Arg2:T1
R12	isAssociatedWith	Arg1:T3	Arg2:T2
R13	isAssociatedWith	Arg1:T3	Arg2:T4
R14	isAssociatedWith	Arg1:T3	Arg2:T5
R15	isAssociatedWith	Arg1:T3	Arg2:T6
R16	isAssociatedWith	Arg1:T4	Arg2:T1
R17	influences	Arg1:T4	Arg2:T2
R18	treats	Arg1:T4	Arg2:T3
R19	isAssociatedWith	Arg1:T4	Arg2:T5
R20	influences	Arg1:T5	Arg2:T2
R21	treats	Arg1:T5	Arg2:T3
R22	isAssociatedWith	Arg1:T5	Arg2:T4
R23	influences	Arg1:T6	Arg2:T2
R24	treats	Arg1:T6	Arg2:T3
R25	influences	Arg1:T6	Arg2:T5
